Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage

Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage

Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2024-01, Vol.103 (3), p.e36963-e36963
Hauptverfasser: Yilmaz, Uğur, Akçaoğlu, Tahsin, Avunduk, Murat Avni, Kaya, Hüseyin, Parça, Osman
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e36963
container_issue 3
container_start_page e36963
container_title Medicine (Baltimore)
container_volume 103
creator Yilmaz, Uğur
Akçaoğlu, Tahsin
Avunduk, Murat Avni
Kaya, Hüseyin
Parça, Osman
description Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recurrent vitreous hemorrhage (RVH). We aimed to investigate the risk factors for RVH after early 25G vitrectomy in diabetic VH. Eighty eyes of eighty patients who underwent early 25G PPV surgery with a diagnosis of VH due to proliferative diabetic retinopathy (PDR) were included in this retrospective study. Vision acuity changes and intraocular pressure (IOP) changes were compared. The effect of arterial hypertension (HT), coronary artery disease (CAD), preoperative antiglaucomatous usage, and anticoagulant usage on RVH was investigated. A value of P 
doi_str_mv 10.1097/MD.0000000000036963
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2917553343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2917553343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-161fd551076640a2d6350e0f1af883c19d624965e7807db73036605acf3f86d83</originalsourceid><addsrcrecordid>eNptkEFPwzAMhSMEYmPwC5BQjlw6nLpJ2iPaYEzaxAXOVdYmW2BtR5JOGr-eThsgIXzxwe892x8h1wyGDDJ5Nx8P4bdQZAJPSJ9xFBHPRHJK-gAxj2Qmkx658P4NgKGMk3PSwzROGE95n3xO6632wS5VsE1NG0PDSlOni9Y5XQe6tcHppvV0pavGuZVadlPr36lRRWicp8oE7ahWbr2jMZ8cDN2o2lFb09KqhQ62-C_nkpwZtfb66tgH5PXx4WX0FM2eJ9PR_SwqECBETDBTcs5ACpGAikuBHDQYpkyaYsGyUsRJJriWKchyIbFDIYCrwqBJRZnigNwecjeu-Wi7Z_PK-kKv16reX5THGZOcIybYSfEgLVzjvdMm3zhbKbfLGeR76Pl8nP-F3rlujgvaRaXLH883ZfwCsxd96Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2917553343</pqid></control><display><type>article</type><title>Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage</title><source>Wolters Kluwer Open Health</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Yilmaz, Uğur ; Akçaoğlu, Tahsin ; Avunduk, Murat Avni ; Kaya, Hüseyin ; Parça, Osman</creator><creatorcontrib>Yilmaz, Uğur ; Akçaoğlu, Tahsin ; Avunduk, Murat Avni ; Kaya, Hüseyin ; Parça, Osman</creatorcontrib><description>Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recurrent vitreous hemorrhage (RVH). We aimed to investigate the risk factors for RVH after early 25G vitrectomy in diabetic VH. Eighty eyes of eighty patients who underwent early 25G PPV surgery with a diagnosis of VH due to proliferative diabetic retinopathy (PDR) were included in this retrospective study. Vision acuity changes and intraocular pressure (IOP) changes were compared. The effect of arterial hypertension (HT), coronary artery disease (CAD), preoperative antiglaucomatous usage, and anticoagulant usage on RVH was investigated. A value of P &lt; .05 was accepted as statistically significant. Postoperative RVH was observed in 18 (22.5%) patients. There was no correlation between the age of the patients and the development of postoperative RVH (r = -0.197, P = .08). The rate of HT and the mean HbA1C levels were found to be higher in the patients who developed RVH than in those who did not (P = .04 and &lt; 0.001, respectively). The presence of CAD, preoperative glaucoma disease, and the use of anticoagulants did not have any effect on RVH (P = .229, 0.843, 0.932, respectively). HT and increased HbA1c were found to be risk factors for RVH in VH patients who underwent 25G vitrectomy in the early period in our study.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000036963</identifier><identifier>PMID: 38241585</identifier><language>eng</language><publisher>United States</publisher><ispartof>Medicine (Baltimore), 2024-01, Vol.103 (3), p.e36963-e36963</ispartof><rights>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c300t-161fd551076640a2d6350e0f1af883c19d624965e7807db73036605acf3f86d83</cites><orcidid>0000-0002-0187-5381</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38241585$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yilmaz, Uğur</creatorcontrib><creatorcontrib>Akçaoğlu, Tahsin</creatorcontrib><creatorcontrib>Avunduk, Murat Avni</creatorcontrib><creatorcontrib>Kaya, Hüseyin</creatorcontrib><creatorcontrib>Parça, Osman</creatorcontrib><title>Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recurrent vitreous hemorrhage (RVH). We aimed to investigate the risk factors for RVH after early 25G vitrectomy in diabetic VH. Eighty eyes of eighty patients who underwent early 25G PPV surgery with a diagnosis of VH due to proliferative diabetic retinopathy (PDR) were included in this retrospective study. Vision acuity changes and intraocular pressure (IOP) changes were compared. The effect of arterial hypertension (HT), coronary artery disease (CAD), preoperative antiglaucomatous usage, and anticoagulant usage on RVH was investigated. A value of P &lt; .05 was accepted as statistically significant. Postoperative RVH was observed in 18 (22.5%) patients. There was no correlation between the age of the patients and the development of postoperative RVH (r = -0.197, P = .08). The rate of HT and the mean HbA1C levels were found to be higher in the patients who developed RVH than in those who did not (P = .04 and &lt; 0.001, respectively). The presence of CAD, preoperative glaucoma disease, and the use of anticoagulants did not have any effect on RVH (P = .229, 0.843, 0.932, respectively). HT and increased HbA1c were found to be risk factors for RVH in VH patients who underwent 25G vitrectomy in the early period in our study.</description><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNptkEFPwzAMhSMEYmPwC5BQjlw6nLpJ2iPaYEzaxAXOVdYmW2BtR5JOGr-eThsgIXzxwe892x8h1wyGDDJ5Nx8P4bdQZAJPSJ9xFBHPRHJK-gAxj2Qmkx658P4NgKGMk3PSwzROGE95n3xO6632wS5VsE1NG0PDSlOni9Y5XQe6tcHppvV0pavGuZVadlPr36lRRWicp8oE7ahWbr2jMZ8cDN2o2lFb09KqhQ62-C_nkpwZtfb66tgH5PXx4WX0FM2eJ9PR_SwqECBETDBTcs5ACpGAikuBHDQYpkyaYsGyUsRJJriWKchyIbFDIYCrwqBJRZnigNwecjeu-Wi7Z_PK-kKv16reX5THGZOcIybYSfEgLVzjvdMm3zhbKbfLGeR76Pl8nP-F3rlujgvaRaXLH883ZfwCsxd96Q</recordid><startdate>20240119</startdate><enddate>20240119</enddate><creator>Yilmaz, Uğur</creator><creator>Akçaoğlu, Tahsin</creator><creator>Avunduk, Murat Avni</creator><creator>Kaya, Hüseyin</creator><creator>Parça, Osman</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0187-5381</orcidid></search><sort><creationdate>20240119</creationdate><title>Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage</title><author>Yilmaz, Uğur ; Akçaoğlu, Tahsin ; Avunduk, Murat Avni ; Kaya, Hüseyin ; Parça, Osman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-161fd551076640a2d6350e0f1af883c19d624965e7807db73036605acf3f86d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yilmaz, Uğur</creatorcontrib><creatorcontrib>Akçaoğlu, Tahsin</creatorcontrib><creatorcontrib>Avunduk, Murat Avni</creatorcontrib><creatorcontrib>Kaya, Hüseyin</creatorcontrib><creatorcontrib>Parça, Osman</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yilmaz, Uğur</au><au>Akçaoğlu, Tahsin</au><au>Avunduk, Murat Avni</au><au>Kaya, Hüseyin</au><au>Parça, Osman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2024-01-19</date><risdate>2024</risdate><volume>103</volume><issue>3</issue><spage>e36963</spage><epage>e36963</epage><pages>e36963-e36963</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>Vitreous hemorrhage (VH) is one of the main causes of vision loss in diabetic retinopathy (DRP). Early surgery increases the visibility of the retina, allowing early recognition of DRP complications and additional treatments. One of the most important reasons affecting success after surgery is recurrent vitreous hemorrhage (RVH). We aimed to investigate the risk factors for RVH after early 25G vitrectomy in diabetic VH. Eighty eyes of eighty patients who underwent early 25G PPV surgery with a diagnosis of VH due to proliferative diabetic retinopathy (PDR) were included in this retrospective study. Vision acuity changes and intraocular pressure (IOP) changes were compared. The effect of arterial hypertension (HT), coronary artery disease (CAD), preoperative antiglaucomatous usage, and anticoagulant usage on RVH was investigated. A value of P &lt; .05 was accepted as statistically significant. Postoperative RVH was observed in 18 (22.5%) patients. There was no correlation between the age of the patients and the development of postoperative RVH (r = -0.197, P = .08). The rate of HT and the mean HbA1C levels were found to be higher in the patients who developed RVH than in those who did not (P = .04 and &lt; 0.001, respectively). The presence of CAD, preoperative glaucoma disease, and the use of anticoagulants did not have any effect on RVH (P = .229, 0.843, 0.932, respectively). HT and increased HbA1c were found to be risk factors for RVH in VH patients who underwent 25G vitrectomy in the early period in our study.</abstract><cop>United States</cop><pmid>38241585</pmid><doi>10.1097/MD.0000000000036963</doi><orcidid>https://orcid.org/0000-0002-0187-5381</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2024-01, Vol.103 (3), p.e36963-e36963
issn 0025-7974
1536-5964
language eng
recordid cdi_proquest_miscellaneous_2917553343
source Wolters Kluwer Open Health; DOAJ Directory of Open Access Journals; IngentaConnect Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
title Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T08%3A14%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigation%20of%20the%20recurrent%20vitreous%20hemorrhage%20risk%20factors%20after%20early%2025G%20vitrectomy%20in%20diabetic%20vitreous%20hemorrhage&rft.jtitle=Medicine%20(Baltimore)&rft.au=Yilmaz,%20U%C4%9Fur&rft.date=2024-01-19&rft.volume=103&rft.issue=3&rft.spage=e36963&rft.epage=e36963&rft.pages=e36963-e36963&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000036963&rft_dat=%3Cproquest_cross%3E2917553343%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2917553343&rft_id=info:pmid/38241585&rfr_iscdi=true